Cargando…
Daylight-Mediated, Passive, and Sustained Release of the Glaucoma Drug Timolol from a Contact Lens
[Image: see text] Timolol, a potent inhibitor of β-adrenergic receptors (βARs), is a first-line drug for decreasing the intraocular pressure (IOP) of patients with glaucoma. Timolol is administered using 0.5% eye-drop solutions at >3 × 10(7) times the inhibitory concentration (k(i)) for βARs. Thi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2018
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311683/ https://www.ncbi.nlm.nih.gov/pubmed/30648151 http://dx.doi.org/10.1021/acscentsci.8b00641 |